Cargando…

Prognostic Impact of Thrombospodin-2 (THBS2) Overexpression on Patients with Urothelial Carcinomas of Upper Urinary Tracts and Bladders

Purpose: Urothelial carcinoma (UC) is a type of tumor, especially of the urinary bladder, that affects people worldwide. Clarification of its detailed tumor biology and discovery of potential targets for developing treatment strategies are imperative because of frequent recurrences and poor prognosi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, I-Wei, Li, Chien-Feng, Lin, Victor Chia-Hsiang, He, Hong-Lin, Liang, Per-In, Wu, Wen-Jeng, Li, Ching-Chia, Huang, Chun-Nung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964138/ https://www.ncbi.nlm.nih.gov/pubmed/27471570 http://dx.doi.org/10.7150/jca.15696

Ejemplares similares

Sulfatase-1 overexpression indicates poor prognosis in urothelial carcinoma of the urinary bladder and upper tract
por: Lee, Hsiang-Ying, et al.
Publicado: (2017)

Complement Component 1, s Subcomponent Overexpression is an Independent Poor Prognostic Indicator in Patients with Urothelial Carcinomas of the Upper Urinary Tract and Urinary Bladder
por: Chang, I-Wei, et al.
Publicado: (2016)

Necdin Overexpression Predicts Poor Prognosis in Patients with Urothelial Carcinomas of the Upper Urinary Tract and Urinary Bladder
por: Chang, I-Wei, et al.
Publicado: (2016)

Downregulation of RNF128 Predicts Progression and Poor Prognosis in Patients with Urothelial Carcinoma of the Upper Tract and Urinary Bladder
por: Lee, Yi-Ying, et al.
Publicado: (2016)

The diagnostic ureteroscopy before radical nephroureterectomy in upper urinary tract urothelial carcinoma is not associated with higher intravesical recurrence
por: Lee, Hsiang-Ying, et al.
Publicado: (2018)

Hypoxia-regulated MicroRNA-210 Overexpression is Associated with Tumor Development and Progression in Upper Tract Urothelial Carcinoma
por: Ke, Hung-Lung, et al.
Publicado: (2017)

CSF-1 Overexpression Predicts Poor Prognosis in Upper Tract Urothelial Carcinomas
por: Hsu, Wei-Chi, et al.
Publicado: (2019)

Low expression of ZSCAN4 predicts unfavorable outcome in urothelial carcinoma of upper urinary tract and urinary bladder
por: He, Hong-Lin, et al.
Publicado: (2023)

Identification of potential genes in upper tract urothelial carcinoma using next-generation sequencing with bioinformatics and in vitro analyses
por: Lee, Hsiang-Ying, et al.
Publicado: (2021)

Molecular Characterization of Urothelial Carcinoma of the Bladder and Upper Urinary Tract
por: Lee, Ji Yun, et al.
Publicado: (2017)

Deduction of Novel Genes Potentially Involved in Upper Tract Urothelial Carcinoma Using Next-Generation Sequencing and Bioinformatics Approaches
por: Lee, Hsiang-Ying, et al.
Publicado: (2019)

CSF2 Overexpression Is Associated with STAT5 Phosphorylation and Poor Prognosis in Patients with Urothelial Carcinoma
por: Lee, Yi-Ying, et al.
Publicado: (2016)

High Expression of 17β-hydroxysteroid Dehydrogenase Type 2 is Associated with a Better Prognosis in Urothelial Carcinoma of the Urinary Tract
por: Wang, Chieh-Tien, et al.
Publicado: (2016)

Bladder tumor recurrence after urothelial carcinoma of the upper urinary tract
por: Lonergan, Peter E., et al.
Publicado: (2020)

The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder
por: van Doeveren, Thomas, et al.
Publicado: (2020)

The Predictive Value of Systemic Immune-Inflammation Index on Bladder Recurrence on Upper Tract Urothelial Carcinoma Outcomes after Radical Nephroureterectomy
por: Chien, Tsu-Ming, et al.
Publicado: (2021)

MCM10 overexpression implicates adverse prognosis in urothelial carcinoma
por: Li, Wei-Ming, et al.
Publicado: (2016)

Prognostic Factors for Contralateral Recurrence of Upper Tract Urothelial Carcinoma after Nephroureterectomy: A Large Multiregional Study
por: Chien, Tsu-Ming, et al.
Publicado: (2021)

DDR2 overexpression in urothelial carcinoma indicates an unfavorable prognosis: a large cohort study
por: Tsai, Meng-Chen, et al.
Publicado: (2016)

Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma
por: D’Andrea, David, et al.
Publicado: (2020)

Role of galectin‐1 in urinary bladder urothelial carcinoma cell invasion through the JNK pathway
por: Shen, Kun‐Hung, et al.
Publicado: (2016)

Comparative analysis of patients with upper urinary tract urothelial carcinoma in black-foot disease endemic and non-endemic area
por: Chang, Che-Wei, et al.
Publicado: (2021)

Role of Microtubule-Associated Protein 1b in Urothelial Carcinoma: Overexpression Predicts Poor Prognosis
por: Chien, Tsu-Ming, et al.
Publicado: (2020)

Validation of Hyponatremia as a Prognostic Predictor in Multiregional Upper Tract Urothelial Carcinoma
por: Yeh, Hsin-Chih, et al.
Publicado: (2020)

The cAMP responsive element binding protein 1 transactivates epithelial membrane protein 2, a potential tumor suppressor in the urinary bladder urothelial carcinoma
por: Li, Chien-Feng, et al.
Publicado: (2015)

Over-expression of Activated Signal Transducer and Activator of Transcription 3 Predicts Poor Prognosis in Upper Tract Urothelial Carcinoma
por: Li, Wei-Ming, et al.
Publicado: (2017)

HER2 Protein Overexpression and Gene Amplification in Plasmacytoid Urothelial Carcinoma of the Urinary Bladder
por: Kim, Bohyun, et al.
Publicado: (2016)

Proteomic Identification of the Galectin-1-Involved Molecular Pathways in Urinary Bladder Urothelial Carcinoma
por: Li, Chien-Feng, et al.
Publicado: (2018)

Comparison of the clonality of urothelial carcinoma developing in the upper urinary tract and those developing in the bladder
por: Wang, Yuding, et al.
Publicado: (2013)

Therapeutic strategies for asymptomatic upper urinary tract urothelial carcinoma
por: Lin, Deng, et al.
Publicado: (2022)

Predominant global glomerulosclerosis in patients of upper urinary tract urothelial carcinoma with pre-existing renal function impairment is a predictor of poor renal outcomes
por: Niu, Sheng-Wen, et al.
Publicado: (2019)

Concurrent Preoperative Presence of Hydronephrosis and Flank Pain Independently Predicts Worse Outcome of Upper Tract Urothelial Carcinoma
por: Yeh, Hsin-Chih, et al.
Publicado: (2015)

Prognostic Value of Comorbidity for Patients with Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy
por: Ke, Hung-Lung, et al.
Publicado: (2022)

DNA Hypomethylation Is Associated with the Overexpression of INHBA in Upper Tract Urothelial Carcinoma
por: Kao, Chien-Chang, et al.
Publicado: (2022)

Characteristics of upper urinary tract urothelial carcinoma in the context of bladder cancer: a narrative review
por: Giudici, Nicola, et al.
Publicado: (2021)

Expression of Spred2 in the urothelial tumorigenesis of the urinary bladder
por: Oda, Shinsuke, et al.
Publicado: (2021)

Tumor distribution affects bladder recurrence but not survival outcome of multifocal upper tract urothelial carcinoma treated with radical nephroureterectomy
por: Sheu, Zai-Lin, et al.
Publicado: (2021)

Recurrent papillary renal cell carcinoma with concomitant ipsilateral upper urinary tract urothelial carcinoma and metachronous urothelial carcinoma of the bladder
por: Banapour, Pooya, et al.
Publicado: (2018)

The prognostic impact of lymph node dissection for clinically node-negative upper urinary tract urothelial carcinoma in patients who are treated with radical nephroureterectomy
por: Hsieh, Hsiang-Chen, et al.
Publicado: (2022)

Recurrence pattern and TP53 mutation in upper urinary tract urothelial carcinoma
por: Chen, Chung-Hsin, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_s33gp85t15m8vb6t7b5he8q0ln